Social Media Perceptions Among Young Adults With Cancer - Online Experiment 2 (SIYAMOS2)

November 4, 2026 updated by: UNC Lineberger Comprehensive Cancer Center

Young adults with cancer experience more loneliness than their non-cancer peers or older cancer survivors. Positive psychology interventions have promise to increase social connectedness; however, evidence-based interventions should be tailored for young adults with cancer and designed for social media. The investigators conducted an online experiment with young adults with cancer (ages 22-39) to examine the most promising message types with personal stories to identify a suite of intervention messages that encourage positive, in-person social interactions with strangers and acquaintances (i.e., weak ties).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This is a between-person online experiment where connected peer advocate and clinician framing and cancer-specific personal stories were used for intervention messages compared to control messages. Participants were randomized (Qualtrics built-in randomizer) evenly to 1 of 4 message panels: intervention panel 1, intervention panel 2, control panel 1, or control panel 2. The investigators hypothesized that intervention messages (vs. control) would lead to greater perceived message effectiveness and intended message reactions.

Study Type

Interventional

Enrollment (Actual)

207

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • University of North Carolina at Chapel Hill, Department of Radiation Oncology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

22 years to 39 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants must be 22-39 years old at the time of the study
  • Participants must have received a cancer diagnosis at any point between ages 15-39
  • Participants must self-report low-to-moderate psychosocial quality of life (QOL), defined as an average rating of 4 or lower on the National Institutes of Health's (NIH's) validated 2-item Patient Reported Outcomes Measurement Information System (PROMIS) global mental health scale (two 5-point items)
  • Participants must use social media

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cancer Peer and Clinician Messages

Participants are randomized to 1 of 2 intervention panels to view and rate 9 social media posts: 6 from socially connected cancer peer advocates and 3 from clinicians, each with a cancer story and advice to have positive in-person interactions with people they barely know.

Participants were randomized to 1 of 4 message panels (intervention 1, intervention 2, control 1, control 2).

Active Comparator: Arm 2: Control - Public Service Announcement Messages

Participants are randomized to 1 of 2 control panels and view and rate 9 public service announcement posts about food safety or password safety.

Participants were randomized to 1 of 4 message panels (intervention 1, intervention 2, control 1, control 2).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Message Effectiveness for In-Person Interactions (Single-Item Self-Report, 5-Point Scale)
Time Frame: Baseline, Up to 1 hour

After viewing each of 9 social media posts, participants answered one item: "How much does this post make you want to interact in person with people you barely know? (This doesn't include online interactions.)" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived message effectiveness for in-person interactions. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive Affect (Single-Item Self-Report, 5-Point Scale)
Time Frame: Baseline, Up to 1 hour

After viewing each of 9 social media posts, participants answered one item: "How good does viewing this post make you feel?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater positive affect. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Perceived Social Presence (single item adapted from Lazard et al., 2020; 5-point agreement scale)
Time Frame: Baseline, Up to 1 hour

After viewing each of 9 social media posts, participants answered one item: "When viewing this post, how much do you feel as if someone is talking to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived social presence. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Message Relevance (Single Item Adapted From Jensen et al., 2024; 5-Point Scale)
Time Frame: Baseline, Up to 1 hour

After viewing each of 9 social media posts, participants answered one item: "How relevant is this post to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived relevance. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour
Perceived Message Effectiveness for Online Interactions (Single-Item Self-Report, 5-Point Scale)
Time Frame: Baseline, Up to 1 hour

After viewing each of 9 social media posts, participants answered one item: "How much does this post make you want to interact online with people you barely know? (Online includes on social media.)" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived message effectiveness for online interactions. Ratings were compared across experimental conditions and message types.

Baseline, Up to 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Allison J Lazard, PhD, UNC Lineberger Comprehensive Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 29, 2025

Primary Completion (Actual)

January 15, 2026

Study Completion (Actual)

January 15, 2026

Study Registration Dates

First Submitted

October 27, 2026

First Submitted That Met QC Criteria

November 4, 2026

First Posted (Actual)

November 10, 2026

Study Record Updates

Last Update Posted (Actual)

November 10, 2026

Last Update Submitted That Met QC Criteria

November 4, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SIYAMOS2 Online Experiment 2
  • R01CA276176 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.